Department of Psychiatry, University of California, San Francisco, San Francisco.
Am J Geriatr Psychiatry. 2013 Apr;21(4):337-45. doi: 10.1016/j.jagp.2012.11.014. Epub 2013 Feb 6.
Ethical guidelines suggest that, when enrolling patients with dementia in research, alterative decision makers (proxies) should base their decision on a "substituted judgment" of how the patient would have decided. If unable to make a substituted judgment, proxies are asked to decide on the basis of the patient's best interests. This mixed-methods study is the first to examine explicitly whether and to what degree proxies differentiate between these two approaches and what considerations influence their mode of decision making.
Interview study regarding enrollment of relative in hypothetical clinical trial of an investigational drug for Alzheimer disease. Participants were randomized to respond to questions about one of four hypothetical clinical trials that differed by levels of described risk and potential benefit.
Proxy decision makers (N = 40).
Open-ended and rating-scaled items.
Half of the proxies agreed with both of two rating-scaled items asking about different approaches to decision making-that is, agreeing that they would decide on the basis of how their relative would have decided and agreeing that they would decide on the basis of what they believed was in their relative's best interests. Narrative responses elaborated on themes within the following three major domains: Substituted judgment, best interests, and weighing substituted judgment and best interests. Substituted judgment was framed as honoring the patient's wishes and values. Best interests was described as a perceived duty to maintain quality of life and avoid burdens or risks. Weighing the two standards emerged as a challenging yet important, way of honoring wishes while maintaining quality of life. An unexpected theme was the attempt by alternative decision makers to discern their loved one's current versus premorbid research preferences.
Tensions exist between abstract ethical principles regarding decision-making "standards" and their translation into research decisions.
道德准则建议,在招募痴呆症患者参与研究时,替代决策者(代理人)应根据患者本人会如何决策的“替代性判断”来做出决策。如果无法做出替代性判断,代理人则应根据患者的最佳利益做出决策。本混合方法研究首次明确检验了代理人是否以及在何种程度上区分了这两种方法,以及哪些因素影响了他们的决策模式。
关于将亲属纳入假设性阿尔茨海默病研究性药物临床试验的访谈研究。参与者被随机分配回答关于四个假设性临床试验的问题,这些试验在描述的风险和潜在获益水平上有所不同。
代理人决策人(N=40)。
开放式和评分量表项目。
一半的代理人对两个询问不同决策方法的评分量表项目表示同意,即同意他们将根据亲属的意愿做出决定,并且同意他们将根据他们认为符合亲属最佳利益的原则做出决定。叙述性回答阐述了以下三个主要领域内的主题:替代性判断、最佳利益以及权衡替代性判断和最佳利益。替代性判断被框定为尊重患者的意愿和价值观。最佳利益被描述为一种维护生活质量、避免负担或风险的感知责任。权衡这两个标准被认为是一种尊重意愿同时维持生活质量的具有挑战性但又重要的方式。一个意想不到的主题是替代决策者试图辨别其亲人当前与发病前的研究偏好。
关于决策“标准”的抽象伦理原则与其在研究决策中的转化之间存在矛盾。